The course is targeted toward people who are interested in how patient experience data and clinical outcome assessment (COA) data can be used as evidence across drug development, in the pharmaceutical industry. By the end of the course you will better understand how this data is collected and analysed to evidence how patients feel, function or survive in the context of a clinical trial. More specifically, the course will cover: i) a background to COAs; ii) a background to patient experience data; iii) how to select, develop/modify and validate COAs using qualitative data (a) and psychometrics (b); iv) interpreting data on a COA; v) measuring treatment related tolerability via patient reported outcomes; vi) Common COA data outputs.
éčæ Coursera Plus ęé«ęč½ļ¼ä» é 239 ē¾å /幓ļ¼åä»· 399 ē¾å ļ¼ćē«å³čē

Data Sciences in Pharma - Patient Centered Outcomes Research

ä½ęåøļ¼Susanne Clinch
2,943 人已注å
å å«åØ äø
22 ę”čÆč®ŗ
ęØčä½éŖ
ęØå°å¦å°ä»ä¹
How patient experience data is used in the drug lifecycle
Developing a patient-centric measurement strategy and using qualitative and quantitative patient experience data as evidence in drug development
Common clinical outcome assessment outputs and considerations when interpreting clinical outcome assessment data
č¦äŗč§£ē详ē»äæ”ęÆ

ę·»å å°ęØēé¢č±ę”£ę”
12 锹ä½äø
äŗč§£é”¶ēŗ§å ¬åøēåå·„å¦ä½ęę”ēéØęč½

评课ēØå ±ę4个樔å
ä½ęåø

ęä¾ę¹
ä» Data Analysis ęµč§ę“å¤å 容
人们为ä»ä¹éę© Coursera ę„åø®å©čŖå·±å®ē°čäøåå±

Felipe M.

Jennifer J.

Larry W.

Chaitanya A.

éčæ Coursera Plus å¼åÆę°ēę¶Æ
ę éå¶č®æé® 10,000+ äøēäøęµē课ēØćå®č·µé”¹ē®åå°±äøå°±ē»ŖčÆä¹¦čÆ¾ēØ - ęęčæäŗé½å å«åØęØē订é äø
éčæåØēŗæå¦ä½ęØåØęØēčäøēę¶Æ
č·åäøēäøęµå¤§å¦ēå¦ä½ - 100% åØēŗæ
å å „č¶ čæ 3400 å®¶éę© Coursera for Business ēå Øēå ¬åø
ęååå·„ēęč½ļ¼ä½æå ¶åØę°åē»ęµäøč±é¢čåŗ






